Target intelligence / Profile preview

Tear proteins and mucins

Molecular classification
Enzyme, Other
01

Overview

Tear proteins and mucins are a heterogeneous group of molecules that constitute the aqueous and mucous layers of the precorneal tear film. Mucins, such as the secreted MUC5AC and membrane-associated MUC1, MUC4, and MUC16, are essential for reducing friction during blinking and maintaining a stable, hydrophilic ocular surface [1][2]. Tear proteins, including lysozyme, lactoferrin, and secretory IgA, provide the primary innate and adaptive immune defense against ocular pathogens [3]. These components work synergistically to prevent desiccation and protect the corneal epithelium from environmental insults. In conditions like dry eye disease, the concentration and quality of these components are often diminished, leading to tear film instability and inflammation [1]. Pharmacological interventions like rebamipide and diquafosol target these components by stimulating their endogenous production to restore the ocular surface microenvironment [4][5].

Other names
Tear film componentsOcular surface mucinsLacrimal proteinsPrecorneal tear film glycoproteinsOcular glycocalyx components
02

Mechanism of action

Stimulation of mucin secretion from conjunctival goblet cells and upregulation of membrane-associated mucin expression to stabilize the tear film and protect the ocular surface.

03

Biological functions

Immune responseOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Ocular irritationBlurred visionHypersensitivity reactionsPreservative-induced toxicity
06

Interacting drugs

Rebamipide

4 more in the full profile.

07

Biomarkers

MUC5AC concentrationTear lysozyme levelsTear lactoferrin levelsTear Break-Up Time (TBUT)Schirmer test scores

Beyond the preview

Go deeper on Tear proteins and mucins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tear proteins and mucins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call